Home » Topics » Disease categories and therapies » Ear, nose and throat

Ear, nose and throat
RSS

Sensorion reports results from phase I study of SENS-218 for inner ear lesions

Sep. 8, 2016

Auris Medical's phase III trial of Keylizen does not meet its two coprimary efficacy endpoints

Aug. 19, 2016

FDA's clinical hold on CGF-166 lifted

July 26, 2016

Auris Medical obtains fast track designation for Keyzilen

July 19, 2016

Strekin begins phase II study of STR-001

April 29, 2016

Boehringer Ingelheim and Kyoto University to investigate new drugs for sensorineural hearing loss

April 5, 2016

Otonomy launches Otiprio in U.S.

March 3, 2016

Oricula Therapeutics receives NIH grant to support development of ORC-13661

Feb. 4, 2016

3D-printed biomimetic tympanic membrane shows similar acoustic properties to human eardrum

Jan. 26, 2016

Sensorion cleared to initiate phase I trial of SENS-218 in U.K.

Jan. 7, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Korsana boosts Alzheimer’s work with reverse merger, $380M financing
BioWorld Science
Just over a month after emerging from stealth and disclosing a $150 million series A, Korsana Biosciences Inc. is making the leap to the public market via a...
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld
Hematopoietic stem cell research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...